Disseminated gonococcal infection (DGI) is a serious complication of gonorrhea that occurs when Neisseria gonorrhoeae spreads through the bloodstream, leading to systemic infection that most commonly affects the skin and joints. As rates of gonorrhea continue to evolve nationally, timely recognition and response to DGI are critical for both clinical care and public health practice.
This session will provide an in-depth overview of the current epidemiology of DGI, including emerging risk factors, host–pathogen interactions, and the role of whole genome sequencing in strain characterization and cluster detection. Participants will learn best practices for identifying and clinically managing DGI, including appropriate diagnostic approaches, recommended treatment regimens, and recognition of potential complications. The course will also highlight effective surveillance strategies and public health response efforts to identify and mitigate outbreaks.
Designed for clinicians, public health professionals, and disease intervention specialists, this training will equip participants with practical tools to improve patient outcomes and strengthen DGI detection and response efforts within their communities.
Learning Objectives
By the end of this session, participants will be able to:
Describe the current epidemiology of DGI, including risk factors, host–pathogen interactions, and the use of whole genome sequencing for strain characterization and cluster detection.
Apply best practices for the identification and clinical management of DGI, including appropriate diagnostic methods, treatment options, and potential complications.
Identify strategies for effective surveillance and public health response to DGI outbreaks.
STI Expert Hour Webinar – Shared Decision Making in Sexual Health: Part 2
March 5, 2026 12:00 PM – 1:30 PM (PT) 1.50 CME units at no cost
Ina Park, MD, MS Professor Department of Family and Community Medicine and Department of Obstetrics, Gynecology, and Reproductive Sciences UCSF School of Medicine PI California Prevention Training Center at UCSF
Patty Cason, RN, MS, FNP-BC President Envision Sexual and Reproductive Health
Course Description
Shared decision making is often recommended as a person-centered way to engage with patients as they make decisions about their health. But what is the best way to have these conversations? In this follow-up session to our prior CAPTC webinar on shared decision making, we will be taking a deeper dive into this topic, focusing on specific scenarios where a shared decision-making approach may help address clinical grey areas in sexual health.
Learning Objectives
Utilize shared decision making in at least two specific clinical scenarios (e.g., doxyPEP or nPEP initiation).
Describe at least two common problems encountered with shared decision-making and how to solve them.
How to Prepare Bicillin® L-A with Lidocaine for Pain Control During Treatment for Syphilis
January 2026. Developed in collaboration with Kristin Harter, PharmD at the University of California, San Francisco, this instructional video provides step-by-step guidance for adding lidocaine to Bicillin® L-A for the mitigation of pain during treatment of syphilis. This resource is intended for healthcare professionals who provide clinical care and are involved in the preparation and administration of these medications.
Additional resources are available from our partners at the Saint Louis STI/HIV Prevention Training Center including a visual guide and printable brochure.
STI Clinical Update Webinar – HCV in 2026: A Clinical Update and Review
January 20, 2026 10:30 am -12:00 pm (PST) 1.5 CME units at no cost Please note: CME not available for viewing the recording of the webinar.
Presenters
Norah Terrault, MD, MPH, FAASLD Professor of Medicine Chief, Division of Gastrointestinal and Liver Diseases Neil Kaplowitz Chair in Liver Diseases Keck School of Medicine of USC University of Southern California
Kurtis Mohr, MD, AAHIVM Public Health Medical Officer, Office of STIs and HCV California Department of Public Health
Course Description
Co-sponsored by the California Department of Public Health and California Prevention Training Center at the University of California San Francisco, this STI Clinical Update webinar will provide a comprehensive review of hepatitis C (HCV) in 2026, focusing on clinical cases and test-to-treat models of care.
Learning Objectives
Understand and apply the test-to-treat model for hepatitis C Participants will learn how to initiate direct-acting antiviral (DAA) therapy at the point of diagnosis, including in community settings, using Dr. Terrault, AASLD or CDPH, or other simplified treatment pathways. Literature supporting the effectiveness and feasibility of test-to-treat will be reviewed.
Use case-based scenarios to identify key clinical considerations Through interactive case studies, providers will explore how to interpret relevant lab values, assess comorbidities, and evaluate potential drug interactions when initiating DAA therapy. Emphasis will be placed on practical decision-making using simplified treatment algorithms.
Implement appropriate monitoring and follow-up during hepatitis C treatment Attendees will learn recommended baseline and follow-up laboratory testing, including HCV RNA viral load timing, and understand whether there is a need for and the frequency and purpose of clinical follow-up visits throughout the treatment course.
To request an accommodation for this event, please email captc@ucsf.edu at least a week in advance of the event.
STI Expert Hour Webinar – Male Partner Treatment to Prevent BV Recurrence: Evidence and Implementation
December 18, 2025 1:30 pm – 2:50 pm (PST)
Please note: CME not available for viewing the webinar recording.
Presenter
Catriona Bradshaw, MMBS(Hons), FAChSHM, FAHMS, PhD Professor Melbourne Sexual Health Centre, Alfred Health School of Translational Medicine, Monash University Melbourne School of Population and Global Health, University of Melbourne
Course Description
This seminar will discuss the epidemiological and microbiological evidence and pilot data that led to the StepUp randomised controlled trial (RCT) – an RCT that demonstrated treating male partners with a combination of oral and topical antimicrobials at the time a women is being treated for bacterial vaginosis (BV) significantly improved cure over 12 weeks. The trial methodology and findings will be presented in detail. The seminar will have a focus on the practicalities of implementation and prescribing including examples of free online resources available to assist clinicians in discussing and providing partner treatment for BV, consumer resources to assist informed decision making, and qualitative research findings. Time will be made available for audience discussion and participation.
Learning Objectives
Participants will be able to understand the rationale and evidence for male partner treatment for BV and apply this new knowledge to their clinical practice.
Participants will be able to discuss partner treatment for BV with their patients, facilitate shared decision making, understand where to access evidence-based resources, and make informed decisions regarding the provision of this intervention for heterosexual couples.
STI Clinical Update Webinar – Congenital Syphilis Scenarios: A case-based overview
April 28, 2025 12:00PM -1:15PM (PDT) CME not offered for viewing the webinar recording.
Course Description
This presentation reviews four separate cases of congenital syphilis (CS). Each case illustrates one of the four CS Scenarios, as defined by the Centers for Disease Control and Prevention (CDC). Through these cases, learners will gain an understanding of the diagnosis and management of the CDC CS Scenarios. The cases are shown from two viewpoints: a clinical pediatric infectious disease perspective and a public health medical officer standpoint.
Learning Objectives
Describe the diagnostic criteria for the four congenital syphilis scenarios, as described by the Centers for Disease Control and Prevention
Identify at least one public health resource for congenital syphilis management
Understand the different lab tests that can be used to evaluate an infant exposed to syphilis during pregnancy.
Presenters
Elizabeth Partridge, MS, MD, MPH Dr. Partridge is an Associate Clinical Professor of Pediatric Infectious Diseases at the UC Davis Medical Center (UCDMC) in Sacramento, CA. She provides inpatient and outpatient consultation for children with acute and chronic infections. Dr. Partridge serves as medical director of infection prevention for the UC Davis Children’s Hospital. Her clinical and research interests include hospital epidemiology & infection prevention. She has a special clinical interest in the prevention and management of congenital Syphilis infection.
Rosalyn Plotzker, MD, MPH Dr. Plotzker is an Assistant Professor in the UCSF Department of Epidemiology and Biostatistics and also performs high-resolution anoscopy at the UCSF Anal Neoplasia Clinic, Research, and Education (ANCRE) Center. She completed a Fellowship in Sexually Transmitted Diseases with the CAPTC and the California Department of Public Health (CDPH). She serves as a Public Health Medical Officer in the STD Control Branch at CDPH.
To request an accommodation for this event, please email captc@ucsf.edu at least a week in advance of the event.
NNPTC Syphilis Series: Congenital Syphilis & Syphilis in Pregnancy
In the last installation of NNPTC’s 3 part Syphilis Series, learn from experts Dr. Jason Zucker of the New York City STI PTC & Dr. Erica Hardy of the Sylvie Ratelle STI/HIV PTC.
Case Based Discussions on Congenital Syphilis & Syphilis in Pregnancy
Learning Objectives
Describe the importance of interprofessional collaboration in sexual health care.
Describe current STD/HIV screening strategies including diagnostic algorithms.
Describe current STD/HIV treatment recommendations.
In the second installation of NNPTC’s three part Syphilis Series, learn from our NNPTC experts, Dr. Khalil Ghanem of the PTC at Johns Hopkins & Dr. Arlene Sena of the Southeast PTC.
Case based discussions of clinical conundrums
Experts walk through cases & make treatment decisions
Learning Objectives
Describe the importance of interprofessional collaboration in sexual health care.
Describe current STD/HIV screening strategies including diagnostic algorithms.
Describe current STD/HIV treatment recommendations.
STI Expert Hour Webinar: Shared Decision Making in Sexual Health
Tuesday, February 25, 2025 11:30AM-12:45PM (PST) 1.25 CME units at no cost
Recording currently unavailable. Please note: No CME available for viewing the webinar recording.
Presenter Patty Cason, MS, FNP-BC President, Envision Sexual and Reproductive Health
Course Description A plethora of national guidelines recommend shared decision making as a person-centered way to engage with patients who are making decisions about their health. The goal is for patients to benefit from the provider’s contribution of scientific information while being acknowledged as the experts on themselves. This session will provide a specific, detailed approach to this and language suggestions to operationalize shared decision-making conversations.
Learning Objectives
Define shared decision making
Describe three contributions a provider makes during a shared decision-making conversation
List four ways to acknowledge a patient
STI Expert Hour Webinar – Adolescent Sexual Health: Influences, Trends, and How Healthcare Providers can Support Adolescent Sexual Health and Wellbeing
December 3, 2024 11:30AM-1:00PM (PST)
Registration closes on December 2nd at 3:00PM (PST). Recording available 2 weeks after the webinar. CME not available for viewing the webinar recording.
Presenter
Claudia Borzutzky, MD
Clinical Professor of Pediatrics, Keck School of Medicine at USC Chief, Division of Adolescent and Young Adult Medicine, Children’s Hospital Los Angeles/Keck School of Medicine at USC Medical Director for Adolescent Health, Planned Parenthood Los Angeles
Course Description
Sexuality is a normal part of healthy adolescent development, yet milestones of teens’ sexual development vary widely in terms of timing, cultural acceptance and how supported they are, and associated risks for adverse health outcomes. Dr. Claudia Borzutzky, an adolescent medicine specialist, will present an overview of:
the importance of confidential care for teens, both in primary care and sexual health settings
supporting adolescent sexual wellbeing
trends in use of contraception and condoms, teen pregnancy, and STIs among teens
the intersection of mental health, gender diversity, and the COVID epidemic with adolescent sexual health
Learning Objectives
Integrate understanding of adolescent consent and confidentiality laws in California in order to optimize your practice and lower barriers to care
Explain the difference between risk reduction and the promotion of well-being, in the context of adolescent sexual health
Describe teen-centered approaches to promotion of sexual well-being, and reducing rates of STIs and undesired pregnancy
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
